Potential Long on 1D · Score 58 · Relative volume 1.09x.
Scanner Logic 1.93 | Proof Rev 3.18
Stop Watching The Market. Start Knowing Where To Look.
Integrity Trading ranks the opportunities that deserve attention now, then explains why each one matters, what supports or conflicts with the direction, and what to watch next—so more market data becomes fewer, clearer decisions.
Evidence-ranked opportunitiesPlain-English explanationsLive intelligence + alerts
We don’t show you more market data—we tell you what actually matters.
Current directional observation | Aug 2HOME/USDT | Seller Exhaustion | Current move -8.02%Crypto · Direction confirmed · follow-through under review · observed Aug 2, 4:27 PM ET.Open The Same Deep Ticker Workflow Users Receive
Select a real scanner row, then open each full screen: the ranked scanner, Ticker Intel with market context, a real cached pinned chart, the risk and evidence map, and the ticker-specific proof and community record.
Live ScannerStock sample workspaceSTEP 1 · LIVE SCANNERStart with the actual ranked stock rowsSelect any ticker below. The same symbol carries into Ticker Intel, the pinned chart, risk details, and proof.
STOCKSPotential SetupsReal rows from the last available US stock snapshot
5m15m1H4H1D1W
What do the stages mean?
- Stage 1End Move SpottedA directional receipt begins.
- Stage 2Direction ConfirmedThe Stage 1 receipt passes its direction condition.
- Stage 3Retesting LevelDirection remains confirmed while price tests whether the measured level will hold.
- Stage 4Retest HeldPrice retested and renewed the required directional alignment.
- Stage 5Retest Failed / ExitThe earlier directional condition no longer holds.
- Closed ReceiptTerminal audit statusHistorical receipts remain outside the five active stages.
Directional tracking starts at Stage 1. A Stage 1 receipt passes only when the measured direction confirms at Stage 2.
| # | Ticker | Direction | Stage | TF | Score | Price | Change % | Sector | Support | Resistance | R.Vol | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TickerNVDANVIDIA CORP | DirectionPotential Long | StageStage 1 | 1D | ScoreScore 58 | Price$190.01 | Change-3.55% | Semiconductors & Related Devices | $189.80 | $236.54 | 1.09x |
ExplainChartDetails
Levels & evidence
Support$189.80
Resistance$236.54
Relative volume1.09x
Timeframe1D
|
| 2 | TickerAMDADVANCED MICRO DEVICES INC | DirectionPotential Long | StageStage 1 | 1D | ScoreScore 57 | Price$429.56 | Change-5.51% | Semiconductors & Related Devices | $424.03 | $584.73 | 1.08x |
ExplainChartDetails
Levels & evidence
Support$424.03
Resistance$584.73
Relative volume1.08x
Timeframe1D
|
| 3 | TickerINTCINTEL CORP | DirectionPotential Long | StageStage 1 | 1D | ScoreScore 58 | Price$81.88 | Change-5.12% | Semiconductors & Related Devices | $81.79 | $142.35 | 1.16x |
ExplainChartDetails
Levels & evidence
Support$81.79
Resistance$142.35
Relative volume1.16x
Timeframe1D
|
| 4 | TickerMUMicron Technology, Inc. | DirectionPotential Long | StageStage 1 | 1D | ScoreScore 61 | Price$739.00 | Change-9.94% | Semiconductors & Related Devices | $737.88 | $1255.00 | 1.39x |
ExplainChartDetails
Levels & evidence
Support$737.88
Resistance$1255.00
Relative volume1.39x
Timeframe1D
|
| 5 | TickerBIOABIOAGE LABS, INC. | DirectionPotential Long | StageStage 3 | 1H | ScoreScore 84 | Price$9.04 | Change-63.62% | Pharmaceutical Preparations | $8.65 | $25.14 | 6.32x |
ExplainChartDetails
Levels & evidence
Support$8.65
Resistance$25.14
Relative volume6.32x
Timeframe1H
|
SELECTED TICKER · LIVE WORKSPACENVDA $190.01NVIDIA CORP
-3.55%
NVDA: Potential LongStage 1 - End Move Spotted
STEP 1 OF 5 · SCAN
Select a stock setup worth reviewing
NVDA is selected from the stock scanner. The row keeps price direction, the guide setup, lifecycle stage, score, timeframe, levels, and relative volume visible before deeper review.
TICKER INTEL · FULL EXPLANATIONWhy NVDA appearedScanner evidence, market context, confirmation requirements, and risk are explained together.
The stage must advance with matching price, volume, RSI, and structure evidence.
Current measured evidence can cancel the read. No narrative overrides the fresh scanner state.
SPY +0.72% | QQQ +0.65% | IWM -0.48%. Semiconductors finished +0.30%. Cross-asset read: Oil: Balanced $65-$90 zone | Gold: Balanced move between -1% and +1%.
How to read this: The benchmarks did not all agree, so leadership and individual catalysts matter more than the headline index move. DXY, oil, gold, Bitcoin, volatility, and index breadth can strengthen or weaken a setup’s backdrop, but they never prove the ticker’s cause by themselves.
S $189.80R $236.54
Open Pinned Chart to load real NVDA candlesThe public demo requests the server-managed cache only when this screen is opened. No illustrative candles are shown.
RISK + DETAILS · DECISION MAPNVDA: what must happen nextThis screen separates the setup thesis from the evidence that confirms or cancels it.
- Timeframe
- 1D
- Relative volume
- 1.09x
- Current volume
- 136.6M
- Sector
- Semiconductors & Related Devices
- Confirm the active stage before treating the setup as actionable.
- Compare price behavior with volume and RSI.
- Re-check the broader market backdrop.
- Current stage
- Stage 1 - End Move Spotted
- Support
- $189.80
- Resistance
- $236.54
PROOF + COMMUNITY · TICKER-SPECIFIC HISTORYNVDA stays attached to its evidenceComments and news add context; the saved receipt records what the scanner actually measured.
Staff crowns identify official roles. Community opinions never replace the chart, measured structure, or the condition that changes the read.
Only ticker-specific linked sources are shown. A headline can explain a catalyst, but it does not rewrite the scanner’s recorded setup.
Open observations are not displayed as wins. The current receipt preserves direction, stage evidence, timestamps, and the observed outcome.
From Raw Data To A Clear ReviewWhat changed, why it matters, and what to inspect next.
Evidence-ranked markets narrow thousands of changing signals to the few current rows most worth reviewing.
Ticker Workspace turns the available price, volume, level, event, peer, and fundamental evidence into one plain-English executive summary.
Confidence, missing evidence, support, resistance, earnings timing, data quality, and the condition that changes the read stay visible beside every developing setup.
Interactive charts connect the explanation to candles, volume, RSI, Fibonacci, support, resistance, and the next confirmation condition.
Branded public cards make Market Regime, Economic Radar, daily intelligence, calendars, and setup receipts useful for groups without exposing private account data.
Every current directional receipt keeps its direction, timeframe, lifecycle evidence, timestamps, and observed outcome. Historical audit details stay internal.
Trust Is Part Of The InterfaceSources, freshness, missing data, and measurement rules.
Verified Member FeedbackReal, consented feedback after multiple market cycles.
Verified customer feedback is being collected.Quotes appear only after multiple market cycles, verified product use, explicit consent, and approval of the exact public wording.
Directional Receipt AccuracyThe same current five-stage, eight-tab directional ledger shown inside the app.
Live Observations · Not Completed CallsToday's current watch from every tab
Aug 2 · developing watches and open measurements stay separate from verified outcomes
Same Live Ledger As Scanner + Track Record
91 tracked · Reset Jul 26, 4:56 PM ET · Updated Aug 2, 4:26 PM ET
Evidence building · 264 closed directional receipts · 41 pending. Current five-stage direction is the public measurement.
Get About Two Months Included · Exact annual totals and renewal terms appear before Stripe checkout.
Plan PricingCompare Plans
OPEN BETA — ACTIVE NOWJoin the Open Beta with no card and no automatic paid conversion.SEPARATE FREE PRO TRIALEligible customers can later choose a 14-day trial with full Pro access. A payment method is required only when that separate Pro trial is started; no subscription charge is collected during the trial.
OPEN BETA
Essential
$39/mo
Less noise across the four core markets.
Annual: $390 billed yearly, save about 17%
- Focus on four core scanner lanes.
- Save a watchlist and review daily market context.
- Keep public proof and measured outcomes visible.
OPEN BETARecommended
Pro
$79/mo
Know which opportunities deserve attention—and why.
Annual: $758 billed yearly, save 20%
- Rank opportunities across all eight markets.
- Explain, chart, risk-check, and track each ticker.
- Add portfolio intelligence, personal alerts, branded sharing, and Priority Customer Support.
OPEN BETA
Elite
$149/mo
Extend the complete Pro intelligence workflow.
Annual: $1,430 billed yearly, save 20%
- Everything in Pro.
- Add long-term research, higher integration capacity, and advanced automation.
Open Beta enrollment is active. Join without a card; no Stripe subscription or automatic conversion starts here. Market data, broker connections, alerts, and advanced features may depend on account status and provider availability. Scanner output is informational only and is not financial advice.